These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18001319)

  • 21. Inflammatory markers in coronary heart disease.
    Madjid M; Willerson JT
    Br Med Bull; 2011; 100():23-38. PubMed ID: 22010105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions.
    Koh KK; Han SH; Quon MJ
    J Am Coll Cardiol; 2005 Dec; 46(11):1978-85. PubMed ID: 16325028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers for the prediction of major adverse cardiovascular events in patients with acute coronary syndrome.
    Zeng Q; Sun XN; Ma LH; Chen L; Wang Y; Chen C; Ye ZY; Wu ZH; Li YZ; Xu Y
    Anat Rec (Hoboken); 2010 Sep; 293(9):1512-8. PubMed ID: 20652944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy.
    Miedema MD; Conover CA; MacDonald H; Harrington SC; Oberg D; Wilson D; Henry TD; Schwartz RS
    Am J Cardiol; 2008 Jan; 101(1):35-9. PubMed ID: 18157962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Redefinition of myocardial infarction--relevance of biomarkers].
    Weber M; Hamm C
    Herz; 2008 Mar; 33(2):115-21. PubMed ID: 18344030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins and other agents for vascular inflammation.
    Owens CD
    J Vasc Surg; 2012 Dec; 56(6):1799-806. PubMed ID: 23017371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
    Pradhan AD; Shrivastava S; Cook NR; Rifai N; Creager MA; Ridker PM
    Circulation; 2008 Feb; 117(6):823-31. PubMed ID: 18227386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xinwei J; Xianghua F; Jing Z; Xinshun G; Ling X; Weize F; Guozhen H; Yunfa J; Weili W; Shiqiang L
    Am J Cardiol; 2009 Aug; 104(4):519-24. PubMed ID: 19660605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of intensive statin therapy in the elderly.
    Maroo BP; Lavie CJ; Milani RV
    Am J Geriatr Cardiol; 2008; 17(2):92-100. PubMed ID: 18326948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-conventional markers of atherosclerosis before and after gastric banding surgery.
    Hanusch-Enserer U; Zorn G; Wojta J; Kopp CW; Prager R; Koenig W; Schillinger M; Roden M; Huber K
    Eur Heart J; 2009 Jun; 30(12):1516-24. PubMed ID: 19380349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of statins in patients with acute coronary syndromes].
    Urbinati S; Labanti G; Gambetti S
    G Ital Cardiol (Rome); 2010 Dec; 11(12 Suppl 3):22S-26S. PubMed ID: 21491736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CD40/CD40 ligand system: linking inflammation with atherothrombosis.
    Antoniades C; Bakogiannis C; Tousoulis D; Antonopoulos AS; Stefanadis C
    J Am Coll Cardiol; 2009 Aug; 54(8):669-77. PubMed ID: 19679244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurohumoral and inflammatory activation in patients with coronary artery disease treated with statins.
    Van de Veire NR; Philippé J; De Winter O; Langlois M; Bernard D; De Sutter J
    Heart; 2006 Dec; 92(12):1858-9. PubMed ID: 17105891
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes.
    Mega JL; Morrow DA; de Lemos JA; Mohanavelu S; Cannon CP; Sabatine MS
    J Am Coll Cardiol; 2008 Jun; 51(25):2422-9. PubMed ID: 18565400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in biomarkers of cardiovascular disease (CVD) in active acromegaly.
    Boero L; Manavela M; Gómez Rosso L; Insua C; Berardi V; Fornari MC; Brites F
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):88-95. PubMed ID: 19128365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-reactive protein, stroke, and statins.
    Angerio AD; Bialko MF; White BM
    Crit Care Nurs Q; 2007; 30(2):161-5. PubMed ID: 17356357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.
    Anderson JL
    Am J Cardiol; 2008 Jun; 101(12A):23F-33F. PubMed ID: 18549868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute coronary syndromes: to CRP or not to CRP?
    Biasucci LM; Liuzzo G; Crea F
    J Am Coll Cardiol; 2008 Oct; 52(18):1500; author reply 1500-1. PubMed ID: 19017520
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.